<--- Back to Details
First PageDocument Content
GlaxoSmithKline / Glucocorticoids / Organofluorides / Chronic lower respiratory diseases / Chronic obstructive pulmonary disease / Fluticasone/salmeterol / Formoterol / Fluticasone propionate / Salmeterol / Pulmonology / Medicine / Respiratory therapy
Date: 2015-04-22 23:39:46
GlaxoSmithKline
Glucocorticoids
Organofluorides
Chronic lower respiratory diseases
Chronic obstructive pulmonary disease
Fluticasone/salmeterol
Formoterol
Fluticasone propionate
Salmeterol
Pulmonology
Medicine
Respiratory therapy

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 93,30 KB

Share Document on Facebook

Similar Documents

Microsoft Word - Prosonix full abstract for DDL22_2_.doc

Microsoft Word - Prosonix full abstract for DDL22_2_.doc

DocID: 1rcKt - View Document

COPD Care Map for Primary Care  Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________

COPD Care Map for Primary Care Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________

DocID: 1qO6l - View Document

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

DocID: 1oNoo - View Document

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

DocID: 1ooQZ - View Document

PIPELINE WATCH  Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European

PIPELINE WATCH Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European

DocID: 1mZXk - View Document